GTBP Research and Charts

GTBP - GT Biopharma Inc (Healthcare: Biotechnology)

Projected Earnings Date: 0000-02-29 (Delayed quote data 2026-02-10)

Last 0.52	Change ⇑ +0.04 (+0.00%)	Volume 692,423
	Open 0.49	High 0.53	Low 0.49

8EMA (Daily) 0.55	40EMA (Daily) 0.66	50EMA (Daily) 0.68	STO (Daily) 31.870	MACD Hist (Daily) -0.012
8EMA (Weekly) 0.646	40EMA (Weekly) 1.23	50EMA (Weekly) 1.54	STO (Weekly) 23.327	MACD Hist (Weekly) 0.023


Company Profile
GT Biopharma Inc is an immuno-oncology company operating in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.